featured
Balloon Pulmonary Angioplasty vs Riociguat for Inoperable Chronic Thromboembolic Pulmonary Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study
Lancet Respir Med 2022 Aug 01;[EPub Ahead of Print], X Jaïs, P Brenot, H Bouvaist, M Jevnikar, M Canuet, C Chabanne, A Chaouat, V Cottin, P De Groote, N Favrolt, D Horeau-Langlard, P Magro, L Savale, G Prévot, S Renard, O Sitbon, F Parent, R Trésorier, C Tromeur, C Piedvache, L Grimaldi, E Fadel, D Montani, M Humbert, G SimonneauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.